HCA Healthcare, Inc.

HCA Healthcare Medical Care Facilities

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.

457.58 10.92 −2.33%
Market cap
$101.4B
P/E
15.3×
Fwd P/E
12.3×
Dividend yield
0.67%
F-score
7/9
Altman Z
2.80
Beneish M
−2.87
Dividend safety
78/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
10.17 15.07 11.69 14.68 15.05 12.09 12.65 14.51 13.66 16.45
Piotroski F-Score
8 6 7 7 6 7 5 7 8 7
P/S ratio
0.69 0.74 0.93 0.98 1.08 1.41 1.17 1.15 1.10 1.46
Altman Z-Score
2.10 2.08 2.29 2.35 2.46 2.89 2.54 2.54 2.54 2.80
Altman Z″-Score (non-manufacturers)
1.05 1.10 1.13 1.40 1.66 1.81 1.49 1.36 1.22 0.92
P/FCF ratio
9.87 13.45 13.56 14.64 8.70 15.43 17.11 16.00 13.76 14.35
Beneish M-Score
(2.81) (2.73) (2.71) (2.71) (2.97) (2.46) (2.57) (2.66) (2.73) (2.87)
P/Operating CF
16.81 18.70 19.87 20.13 (15.53) 34.00 27.94 28.05 30.33 46.79
Dividend Safety Score
— — — — — — — — — 78
P/B ratio
0.00 0.00 0.00 0.00 19.24 55.79 0.00 70.75 139.86 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.43 1.48 1.62 1.63 1.65 1.98 1.79 1.75 1.68 2.06
EV/EBITDA
7.19 7.84 8.41 8.45 8.43 9.17 8.91 8.91 8.53 9.98
EV/Operating CF
10.49 11.93 11.17 10.99 9.19 12.97 12.65 12.05 11.29 12.33
EV/FCF
20.50 26.86 23.70 24.26 13.26 21.59 26.12 24.25 21.05 20.26
Quick Ratio
1.11 1.17 0.96 1.03 1.02 1.00 0.99 0.86 0.84 0.73
Current Ratio
1.56 1.62 1.35 1.44 1.42 1.41 1.38 1.18 1.08 0.97
Net Debt/EBITDA
3.72 3.91 3.60 3.35 2.90 2.61 3.07 3.03 2.95 2.91
Debt/Assets
92.94% 90.34% 83.71% 74.84% 65.29% 68.15% 72.63% 70.44% 72.31% 76.57%
Debt/Equity
(5.57) (6.62) (11.25) (59.68) 10.72 23.22 (521.70) 37.35 77.53 (16.78)
Asset Turnover
1.25 1.24 1.23 1.22 1.11 1.20 1.17 1.20 1.22 1.26
Operating CF/Net income
1.96 2.45 1.79 2.17 2.46 1.29 1.51 1.80 1.83 1.86
Capex/Depreciation
(1.38) (1.39) (1.55) (1.58) (1.03) (1.24) (1.47) (1.52) (1.46) (1.39)
Interest Coverage
3.66 3.61 3.80 3.98 4.62 6.25 5.23 4.98 5.13 5.36
ROE
(49.49%) (41.70%) (95.72%) (201.26%) 322.65% 317.55% 797.03% 1,062.21% 713.31% (612.27%)
ROA
8.69% 6.30% 9.99% 8.32% 8.11% 14.16% 10.94% 9.65% 9.95% 11.28%
ROIC
15.57% 13.95% 14.18% 13.95% 14.24% 17.68% 15.33% 15.18% 15.86% 17.64%
Return on Tangible Assets
14.74% 10.21% 16.91% 13.40% 13.99% 24.82% 19.25% 17.48% 18.79% 22.19%
Average Days of Receivables
51.25 54.41 53.09 52.47 49.94 50.29 53.88 55.95 55.58 52.47
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
45.55% 45.99% 45.90% 45.89% 46.33% 45.58% 45.96% 45.39% 44.15% 43.46%
Intangible Assets out of Total Assets
0.20 0.20 0.20 0.18 0.18 0.19 0.18 0.18 0.17 0.17
Share Based Compensation of Revenue
0.60% 0.62% 0.57% 0.68% 0.70% 0.75% 0.57% 0.40% 0.51% 0.53%
Graham Net Nets
(1.06) (0.97) (0.74) (0.68) (0.58) (0.43) (0.55) (0.54) (0.55) (0.43)
Graham Number
0.00 0.00 0.00 0.00 45.85 46.93 0.00 40.76 32.57 0.00
Earnings Yield
9.83% 6.64% 8.56% 6.81% 6.65% 8.27% 7.91% 6.89% 7.32% 6.08%
Free Cash Flow Yield
10.13% 7.43% 7.38% 6.83% 11.50% 6.48% 5.84% 6.25% 7.26% 6.97%
Revenue per Share
108.16 120.38 134.40 150.45 152.34 181.72 207.45 238.50 273.02 319.78
Operating CF per Share
14.74 14.98 19.47 22.28 27.29 27.71 29.35 34.62 40.66 53.45
Capex per Share
(7.20) (8.32) (10.29) (12.19) (8.38) (11.06) (15.14) (17.42) (18.85) (20.91)
Free Cash Flow per Share
7.54 6.65 9.18 10.09 18.91 16.65 14.21 17.21 21.81 32.54
Cash per Share
1.68 2.02 1.45 1.82 5.30 4.49 3.13 3.43 7.47 4.40
Shareholders Equity per Share
(14.68) (13.79) (8.40) (1.66) 8.55 4.61 (0.25) 3.89 2.15 (11.72)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(14.68) (13.79) (8.40) (1.66) 8.55 4.61 (0.25) 3.89 2.15 (11.72)
Free Cash Flow
2,893.00 2,411.00 3,188.00 3,444.00 6,397.00 5,382.00 4,127.00 4,687.00 5,639.00 7,692.00
Working Capital
3,252.00 3,819.00 2,644.00 3,439.00 3,629.00 3,960.00 3,741.00 2,272.00 1,237.00 (567.00)
Capital Expenditures
(2,760.00) (3,015.00) (3,573.00) (4,158.00) (2,835.00) (3,577.00) (4,395.00) (4,744.00) (4,875.00) (4,944.00)
Net Current Asset Value
(30,305.00) (31,611.00) (31,912.00) (34,427.00) (32,265.00) (35,711.00) (38,868.00) (40,224.00) (42,544.00) (47,708.00)
EV/EBIT
9.48 10.61 11.32 11.50 11.60 11.87 11.85 11.78 11.23 12.94
Capex to Sales
0.07 0.07 0.08 0.08 0.06 0.06 0.07 0.07 0.07 0.07
Price to Operating Income
4.57 5.31 6.48 6.95 7.60 8.48 7.76 7.77 7.34 9.16
Other line items
Depreciation/Fixed assets
0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.11 0.11 0.11
Cash ROIC
10.96% 8.37% 10.49% 10.20% 17.92% 14.34% 10.60% 11.27% 12.39% 17.18%
Accounts Receivable Turnover
7.08 7.08 7.02 7.25 7.14 7.76 7.09 6.89 6.82 6.99
Accounts Payable Turnover
3.09 2.97 2.98 3.09 2.60 2.48 2.24 2.34 2.53 2.54
Inventory Turnover
4.71 4.76 4.67 4.74 4.32 4.73 4.62 4.84 5.72 6.71
Average Days of Payables
122.04 130.02 121.78 125.02 154.17 158.27 165.11 156.03 145.12 149.60
Days of Inventory on Hand
79.13 78.48 81.85 79.58 88.32 76.46 80.55 74.50 58.98 53.05
Average Receivables
5,857.50 6,163.50 6,645.00 7,084.50 7,215.50 7,573.00 8,493.00 9,424.50 10,354.50 10,809.00
Average Payables
2,244.00 2,462.00 2,591.50 2,741.00 3,220.00 3,823.00 4,175.00 4,236.00 4,254.50 4,467.50
Average Inventory
1,471.00 1,538.00 1,652.50 1,790.50 1,937.00 2,005.50 2,027.00 2,044.50 1,879.50 1,695.00
Average Assets
33,251.00 35,175.50 37,900.00 42,132.50 46,274.00 49,116.00 51,590.00 54,324.50 57,862.00 60,116.50
Average Common Equity
(5,839.50) (5,314.00) (3,956.50) (1,741.50) 1,163.50 2,190.50 708.00 493.50 807.50 (1,108.00)

Fold the line items

Columns are period end dates